RBF Capital’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Sell |
150,000
-100,359
| -40% | -$68K | ﹤0.01% | 559 |
|
|
2025
Q1 | $92.6K | Hold |
250,359
| – | – | 0.01% | 534 |
|
|
2024
Q4 | $179K | Hold |
250,359
| – | – | 0.01% | 502 |
|
|
2024
Q3 | $280K | Hold |
250,359
| – | – | 0.01% | 509 |
|
|
2024
Q2 | $273K | Hold |
250,359
| – | – | 0.02% | 487 |
|
|
2024
Q1 | $318K | Hold |
250,359
| – | – | 0.02% | 456 |
|
|
2023
Q4 | $348K | Hold |
250,359
| – | – | 0.02% | 430 |
|
|
2023
Q3 | $351K | Hold |
250,359
| – | – | 0.02% | 400 |
|
|
2023
Q2 | $461K | Hold |
250,359
| – | – | 0.03% | 373 |
|
|
2023
Q1 | $608K | Hold |
250,359
| – | – | 0.04% | 314 |
|
|
2022
Q4 | $359K | Hold |
250,359
| – | – | 0.03% | 386 |
|
|
2022
Q3 | $559K | Hold |
250,359
| – | – | 0.05% | 307 |
|
|
2022
Q2 | $643K | Hold |
250,359
| – | – | 0.04% | 309 |
|
|
2022
Q1 | $730K | Hold |
250,359
| – | – | 0.05% | 316 |
|
|
2021
Q4 | $804K | Hold |
250,359
| – | – | 0.05% | 299 |
|
|
2021
Q3 | $886K | Sell |
250,359
-13,553
| -5% | -$48K | 0.05% | 277 |
|
|
2021
Q2 | $837K | Buy |
+263,912
| New | +$837K | 0.05% | 296 |
|